Methods for treating conditions associated with masp-2 dependent complement activation
US-2026062498-A1 · Mar 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Schwaeble Hans-Wilhelm patents
Schwaeble Hans-Wilhelm is listed as an inventor on 77 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Schwaeble Hans-Wilhelm |
| Total patents | 77 |
| First publication | Feb 10, 2015 |
| Latest publication | Mar 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
US-2026049158-A1 · Feb 19, 2026 · US
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
US-2026035483-A1 · Feb 5, 2026 · US
Methods for inhibiting fibrosis in a subject in need thereof
US-2025092157-A1 · Mar 20, 2025 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2025059299-A1 · Feb 20, 2025 · US
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
US-2024424091-A1 · Dec 26, 2024 · US
Methods for inhibiting angiogenesis in a subject in need thereof
US-2024352152-A1 · Oct 24, 2024 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2024343830-A1 · Oct 17, 2024 · US
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
US-2024293465-A1 · Sep 5, 2024 · US
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
US-2024254257-A1 · Aug 1, 2024 · US
Recent patents
Latest publications not already listed above.
Methods for treating conditions associated with masp-2 dependent complement activation
US-2024228665-A1 · Jul 11, 2024 · US
Methods for inhibiting fibrosis in a subject in need thereof
US-12005117-B2 · Jun 11, 2024 · US
Methods for inhibiting angiogenesis in a subject in need thereof
US-11981748-B2 · May 14, 2024 · US
Methods for treating conditions associated with MASP-2 dependent complement activation
US-11981749-B2 · May 14, 2024 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2024124611-A1 · Apr 18, 2024 · US
Methods for treating conditions associated with masp-2 dependent complement activation
US-2024076408-A1 · Mar 7, 2024 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2024076409-A1 · Mar 7, 2024 · US
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
US-11896621-B2 · Feb 13, 2024 · US
Methods for treating conditions associated with MASP-2 dependent complement activation
US-11884742-B2 · Jan 30, 2024 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2023391889-A1 · Dec 7, 2023 · US
Targeted catalytic complement-activating molecules and methods of use thereof
US-2023173091-A1 · Jun 8, 2023 · US
Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome
US-11525011-B2 · Dec 13, 2022 · US
Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19
US-2022308056-A1 · Sep 29, 2022 · US
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
US-2022259325-A1 · Aug 18, 2022 · US
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
US-2022242972-A1 · Aug 4, 2022 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2022089781-A1 · Mar 24, 2022 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2022002439-A1 · Jan 6, 2022 · US
Methods for inhibiting fibrosis in a subject in need thereof
US-2021355236-A1 · Nov 18, 2021 · US
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
US-2021290684-A1 · Sep 23, 2021 · US
Methods for inhibiting angiogenesis in a subject in need thereof
US-2021189009-A1 · Jun 24, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Omeros Corp | 74 |
| Univ Leicester | 74 |
| Univ Leicester | 1 |
| Demopulos Gregory A | 1 |
| Dudler Thomas | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/40 | 73 |
| A61K2039/505 | 71 |
| C07K2317/92 | 71 |
| C07K2317/76 | 70 |
| C07K2317/21 | 60 |